Related Experiment Video

Updated: May 16, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Pediatric tuberculosis at Beijing Children's Hospital: 2002-2010

Xi-Rong Wu1, Qing-Qin Yin, An-Xia Jiao

  • 1Beijing Pediatric Research Institute, Beijing Children's Hospital (affiliated with Capital Medical University), Beijing, 56 Nanlishi Rd, Xicheng District, Beijing 100045, China.

Pediatrics
|November 28, 2012
PubMed

Insights

Pediatric tuberculosis (TB) is often severe and extrapulmonary (EPTB) in infants under 1 year. Young age and severe TB increase treatment failure risk, highlighting the need for targeted prevention.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Childhood tuberculosis (TB) presents unique diagnostic and treatment challenges.
  • Understanding the profile of pediatric TB is crucial for effective public health interventions.

Purpose of the Study:

  • To characterize patient demographics, clinical presentation, and treatment outcomes in childhood tuberculosis.
  • To identify risk factors associated with severe forms of pediatric TB and poor treatment response.

Main Methods:

  • A retrospective descriptive study analyzed 1212 pediatric TB patients (0-18 years) treated between 2002-2010.
  • Fisher's exact test was used for statistical analysis of categorical variables.

Main Results:

  • Extrapulmonary TB (EPTB) was prevalent (54%), with tuberculous meningitis and disseminated TB classified as severe TB.
  • Younger children (<5 years) and those from rural areas showed higher rates of EPTB.
  • Children under 1 year with severe TB had poorer treatment outcomes; lack of BCG vaccination and home contact history were risk factors for severe TB.

Conclusions:

  • Infants (<1 year) are disproportionately affected by EPTB and severe TB in a referral hospital setting.
  • Age under 1 year and severe TB are significant risk factors for treatment failure.
  • Pediatric TB prevention and care strategies must prioritize EPTB and severe TB, especially in young children.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...